Vietnam MOH registration 338384

Qualitative test reagents for cells expressing CD2 antigen

VN: Thuốc thử xét nghiệm định tính các tế bào biểu hiện kháng nguyên CD2

BD CD2 (L303.1) PE-Cy7

Vietnam·BD CD2 (L303.1) PE-Cy7·Becton Dickinson Caribe, Ltd.; Becton, Dickinson and Company, BD Biosciences·Registered Dec 29, 2022 – Apr 30, 2023Expired

Registration details

Analysis ID: 338384
Product Type: BD CD2 (L303.1) PE-Cy7
Product Code: 335821

Company information

Manufacturer: Becton Dickinson Caribe, Ltd.; Becton, Dickinson and Company, BD Biosciences
Manufacturer Country: United States
Product Owner: Becton, Dickinson and Company, BD Biosciences
Owner Country: United States
Authorized Representative: SISC VIETNAM EQUIPMENT JOINT STOCK COMPANY

Technical details

Unit: Lọ

Dates and status

Registration Date: Dec 29, 2022
Expiry Date: Apr 30, 2023
Status: Hết hiệu lực

Pricing

Maximum Selling Price: 16840000 VND

About this record

Access comprehensive regulatory information for Qualitative test reagents for cells expressing CD2 antigen in Vietnam's medical device market through Pure Global AI's free database. is registered under number 338384 and manufactured by Becton Dickinson Caribe, Ltd.; Becton, Dickinson and Company, BD Biosciences. The authorized representative in Vietnam is SISC VIETNAM EQUIPMENT JOINT STOCK COMPANY.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.